Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxiredoxin 3 pseudogene 3 (PRDX3P3) is a segment of DNA in the human genome that shares high sequence similarity to the functional peroxiredoxin 3 (PRDX3) gene but lacks the necessary regulatory sequences or coding potential to produce a functional protein[2]. Pseudogenes such as PRDX3P3 typically arise by gene duplication or reverse transcription events and accumulate disabling mutations (frameshifts, premature stop codons) that prevent protein formation. While rare pseudogenes may contribute to gene regulation (e.g., through their RNA), PRDX3P3 has no reported biological function or relevance as a therapeutic target. It should not be confused with the functional PRDX3 gene, which is an antioxidant enzyme involved in mitochondrial redox regulation and has potential relevance in cancer and cell proliferation[1]. Pseudogenes can complicate genetic studies and may be incorrectly annotated in genome databases[2]. PRDX3P3 is best classified as a noncoding, nonfunctional pseudogene, and inclusion as a therapeutic target, receptor, enzyme, etc., is incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxiredoxin 3 pseudogene 3 (PRDX3P3).